Glossary
Acronyms
- 21 CFR
- ACCT
- ACHRI
- ACRC
- ACREC
- ACRO
- ACRP
- ADME
- ADR
- AE
- AHRQ
- AHS
- AI
- ALCOA
- ALCOAC
- ANSI
- APCR
- AR
- ARECCI
- ARO
- AU
- AUC
- BGTD
- BID
- BLA
- CASRAI
- CCCR
- CDA
- CDASH
- CDC
- CDISC
- CDM
- CHLA
- CHR
- CHRC
- CHREB
- CIHR
- CITI
- CMAX
- CMIN
- CMPA
- CONSORT
- CPSA
- CRA
- CRC
- CREBA
- CRF
- CRIO
- CRO
- CRT
- CSA
- CSR
- CTA
- CTA
- CTA-A
- CTCAE
- CTD
- CTMS
- CTSI
- CV
- devices
- devices
- DIN
- DMC
- DMS
- DNase
- DSMB
- DTA
- EC
- eCRF
- eCRT
- EDC
- EDR
- EDTA
- EHR
- EMA
- EMEA
- EMR
- ePRO
- ERB
- ERC
- eSource data
- EU
- FAQs
- FD&C
- FD&C
- FDA
- FDA Form 1572
- FDCA
- FDCA
- FFDCA
- FFDCA
- FFPE
- FOIP
- FPFV
- FPI
- FSI
- FTP
- GCP
- GCRP
- GLP
- GMP
- GoA
- HC
- HIA s.54
- HIA s.54 Research Agreement
- HL7
- HPFB
- HPFBI
- HREB
- HREBA
- HTA
- IATA
- IB
- ICF
- ICH
- IDB
- IDE
- IDE
- IDMC
- IHC
- IND
- IP
- IRB
- ISO
- ITA
- IVRS
- KPI
- KT
- LPC
- LPFV
- LPI
- LPLV
- LPO
- LSC
- LSI
- LSO
- MAA
- MedDRA
- MHRA
- ML
- MOU
- MSDS
- MTA
- MTD
- N2
- NACTRC
- NCR
- NDA
- NHP
- NICHSR
- NIH
- NLM
- NOA
- NOC
- NOC/c
- NOL
- NON
- NSERC
- NSN
- ODM
- OIPC
- OTC
- PBS
- PCERT
- PCR
- PD
- PD sample
- PE
- PG sample
- PHEN
- PHN
- PHREIS
- PhRMA
- PI
- PIA
- PIPEDA
- PK sample
- PMA
- POR
- PRBC
- PRIHS
- PRN
- PRO
- PSEAT
- PTC
- QA
- QC
- QD
- QI
- QI
- QID
- QIU
- QMCR
- QoL
- REB
- REB review
- REBA
- RERC
- RNase
- RWD
- RWE
- SAE
- SAR
- SC
- SCDM
- SCNs
- SD
- SDM
- SDV
- SEM
- SIV
- SMO
- SMO
- SOCRA
- SOCs
- SPC
- SPOR
- SRO
- SSHRC
- SUSAR
- TA
- TCPS2
- TCPS2
- TID
- TMA
- TMF
- TPD
- UAT
- ULI
- UofA
- UofC
- UofL
- US
- UST
- WHMIS
- WHO
- WHO ART
- WHO Drug
- WMA
Terms
A
- Abbreviated protocol
- Abnormality
- Aboriginal peoples
- Absolute Risk Reduction
- Absorption
- Absorption, distribution, metabolism, and excretion
- Academic freedom
- Academy of Physicians in Clinical Research
- Accrued
- Action letter
- Active treatment
- Ad hoc advisor
- Adaptive Platform Trials
- Administrative approval
- Admission criteria
- Advanced Therapeutic Products
- Adverse drug experience
- Adverse drug reaction
- Adverse event
- Adverse Events of Special Interest
- Adverse experience
- Adverse reaction
- Agencies
- Agency for Healthcare Research & Quality
- Aim of study
- Alberta Cancer Clinical Trials
- Alberta Cancer Research Ethics Committee
- Alberta Children's Hospital Research Institute
- Alberta Clinical Research Consortium
- Alberta Health Services
- Alberta Innovates
- Alberta Research Ethics Community Consensus Initiative
- Alberta-specific terminology
- Alpha Error
- Alpha-testing
- Amendment
- American National Standards Institute
- Analysis dataset
- Analysis set
- Analysis variable
- Annual Report Online
- Anonymized
- Anonymized human biological materials
- Anonymized information
- Anonymous human biological materials
- Anonymous information
- Appeal
- Appeal mechanism
- Applicable regulatory requirements
- Applied health research
- Approached participants
- Approached patients
- Approvable letter
- Approval
- Approval letter
- Approved
- Archiving of clinical trial data
- Area under curve
- Arm
- Artificial Intelligence
- As needed
- Ascending doses
- Assent
- Association of Clinical Research Organizations
- Association of Clinical Research Professionals
- Athabasca University
- Attributable
- Attributable, Legible, Contemporaneous, Original, Accurate
- Attributable, Legible, Contemporaneous, Original, Accurate, Complete
- Attribute
- Attribution assessment
- Audit
- Audit certificate
- Audit report
- Audit trail
- Authorization
- Authorized third party
- Autonomy
- Award
B
- Back translation
- Balanced study
- Bandit trial
- Bar code
- Baseline
- Baseline characteristics
- Baseline imbalance
- Basket trial
- Batch
- Bayesian Statistics
- Best practice
- Beta Error
- Beta-testing
- Bias
- Bio-analysis
- Bio-equivalence
- Bioavailability
- Biobank
- Biologic
- Biological marker
- Biological product
- Biological samples
- Biological sampling
- Biologics and Genetic Therapies Directorate
- Biologics Licensing Application
- Biomarker
- Biomedical research
- Biometric Monitoring Technologies
- Biometric signature
- Biospecimen
- Biostatistics
- Blanket consent
- Blind review
- Blinded medication
- Blinded study
- Blinding
- Block randomization
- Branch
- Brand name
- Broad consent
- Buffy coat
C
- Calgary Centre for Clinical Research
- Canadian Health Libraries Association
- Canadian Institutes of Health Research
- Canadian Medical Protective Association
- Capacity
- Carryover effect
- Case Control Studies
- Case history
- Case record form
- Case Report
- Case report form
- Case report tabulations
- Categorical data
- Category A substance (IATA definition)
- Category B substance (IATA definition)
- Causality
- Causality assessment
- CDISC Standard
- Centers for Disease Control and Prevention (US)
- Central monitoring
- Certificate of destruction
- Certified copy
- Chart review
- Chemical name
- CIHR category of research
- Citizen
- Citizen Engagement
- Clarifax
- Class
- Class I Device
- Class II Device
- Class III Device
- Class IV Device
- Clean database
- Clean file
- Clinical (Health) Research
- Clinical clarification
- Clinical data
- Clinical Data Acquisition Standards
- Clinical Data Interchange Standards Consortium
- Clinical Data Management
- Clinical Data Repository
- Clinical Data Warehouse
- Clinical development plan
- Clinical efficacy
- Clinical encounter
- Clinical equipoise
- Clinical management report
- Clinical pharmacology
- Clinical phase of a study
- Clinical research
- Clinical research associate
- Clinical research coordinator
- Clinical research manager
- Clinical significance
- Clinical study
- Clinical study agreement
- Clinical study materials
- Clinical study report
- Clinical trial
- Clinical trial agreement
- Clinical Trial Application
- Clinical Trial Application Amendment
- Clinical trial data
- Clinical trial information
- Clinical Trial Management System
- Clinical trial materials
- Clinical trial site
- Clinical Trial Site Information
- Clinical trial status report
- Clinical trial supplies
- Clinician
- Clinician reported outcome
- Clinician-Scientist
- Closed to accrual
- Cluster Randomized Trial
- Co-investigator
- Code breaker
- Coded data
- Coded human biological materials
- Coded information
- Codelist
- Coding
- Coercion
- Cohort
- Cohort study
- Collaborative Institutional Training Initiative
- Collaborative research
- Collaborative Research and Innovation Opportunities
- Collected
- College of Physicians & Surgeons of Alberta
- Combination product
- Commercial invoice
- Commercialization
- Common Electronic Submissions Gateway
- Common name
- Common Technical Document
- Common Terminology Criteria for Adverse Events.
- Community
- Community engagement
- Community Research Ethics Board of Alberta
- Community-based research
- Comparative bioavailability
- Comparative study
- Comparator
- Compassionate use
- Complete file
- Completed
- Completion
- Compliance
- Complications
- Computer system
- Concentration maximum
- Concentration minimum
- Concern for welfare
- Concomitant medication
- Concomitant treatment
- Confidence intervals
- Confidentiality
- Confidentiality disclosure agreement
- Confirmatory trial
- Conflict of interest
- Conjoint Health Research Ethics Board (UofC)
- Consent
- Consent form
- Consented
- Consented participant
- Consignee
- Consolidated Standards of Reporting Trials
- Consortia Advancing Standards in Research Administration Information
- Container
- Content validity
- Contingency funding
- Continuing ethics review
- Continuing research ethics review
- Contract
- Contract research organization
- Contraindication
- Control
- Control group
- Control number
- Controlled clinical trial
- Controlled terminology
- Controlled Variable
- Controlled vocabulary
- Cooperative group
- Coordinating committee
- Coordinating investigator
- Core principles
- Correlation
- Covariate
- Covenant Health Research Centre
- Critical inquiry
- Cross- over design
- Cross-sectional studies
- Cryogenic freezer
- Cryopreservation
- Cryovial
- Cultural heritage
- Curriculum vitae
- Custodian
- Custodianship
- Cyber-material
D
- Dangerous goods
- Dangerous goods safety mark
- Data
- Data acquisition
- Data capture
- Data clarification
- Data clarification form
- Data cleaning
- Data collection
- Data collection instrument
- Data dictionary
- Data entry
- Data integrity
- Data integrity verification
- Data interchange
- Data linkage
- Data listing
- Data management
- Data management conventions
- Data management plan
- Data management system
- Data model
- Data monitoring
- Data monitoring committee
- Data quality
- Data query
- Data safety monitoring board
- Data security
- Data selection criteria
- Data set
- Data storage
- Data Transfer Agreement
- Data transformations
- Data type
- Data validation
- Data verification
- Database
- Database lock
- Database set-up
- Database unlock
- De-identified
- Debriefing
- Decentralized Clinical Trial
- Decision rule
- Declaration of Helsinki
- Deep Learning
- Delegated research ethics board
- Delegation log
- Demographic data
- Deoxyribonuclease
- Dependent variable
- Deployment
- Derived
- Derived variable
- Development plan
- Development process
- Device
- Diagnostic specimen
- Digital health
- Digital image
- Digital signature
- Direct access
- Direct entry
- Direct identifiers
- Directly identifying information
- Dirty database
- Dirty file
- Discipline
- Disclosure
- Discontinuation
- Disease
- Distribution
- Documentation
- Donor
- Dosage
- Dosage form
- Dosage regimen
- Dosage strength
- Dose
- Dose-ranging studies
- Double-blind
- Double-dummy technique
- Drop-out
- Drug
- Drug accountability
- Drug development
- Drug free period
- Drug identification number
- Drug study
- Drug trial
- Dry ice
- Duration of the study
- Duration of treatment
E
- E-Research
- eCertified copy
- eClinical trial
- Edit check
- Effect
- Effectiveness
- Efficacy
- Electronic case report form
- Electronic case report tabulation
- Electronic Clinical Outcome Assessment
- Electronic Common Technical Document
- Electronic data capture
- Electronic Health Record
- Electronic Medical Record
- Electronic Patient Reported Outcome
- Electronic record
- Electronic signature
- Electronic source data
- Eligibility assessment
- Eligible participant
- Emergency drug release
- End-point
- Enrolled
- Enrollment closed
- Entered participant
- Epidemiological
- Equipoise
- Equivalence trial
- Escape medication
- eSignature
- eSource
- eSource data
- eSource document
- Essential documents
- Ethics committee
- Ethics review board
- Ethics review committee
- Ethnicity
- Ethylenediamine tetra-acetate
- European Commission
- European Medicines Agency
- European Union
- Evaluable participant
- Evaluation
- Every day
- Exclusion criteria
- Excretion
- Expanded Access
- Experiment
- Expiry date
- Exploratory IND study
- Exploratory study
- External audit
F
- Failure Mode and Effects Analysis
- Federal Food, Drug and Cosmetics Act
- Field
- Field of application
- File Transfer Protocol
- Final monitoring visit
- Final study report
- Financial agreement
- First participant in
- First participant screened
- First participant treated
- First patient first visit
- First subject in
- First subject screened
- First subject treated
- First-in-humans study
- First-in-man study
- Food & Drug Administration
- Food, Drug and Cosmetics Act
- Formalin-fixed paraffin embedded
- Four times daily
- Fraud
- Freedom of Information and Protection of Privacy Act
- Frequentist methods
- Frequently Asked Questions
- Frozen
- Full research ethics board
- Funding source
G
H
- H + E Stain
- Half-life
- Handling
- Health Canada
- Health Information Act
- Health Level 7
- Health Products and Food Branch
- Health Products and Food Branch Inspectorate
- Health research
- Health research data
- Health Research Ethics Board (U of A, AHS, Covenant Health, U of L)
- Health Research Ethics Board of Alberta
- Health services research
- Health system data
- Health Technology
- Health Technology Assessment
- Healthcare provider
- Healthy volunteer
- Heat Map
- HIA Research Agreement
- HIA s.54 Research Agreement
- Highly Qualified Personnel
- Human biological materials
- Human subject
- Hypothesis
I
- IATA
- Identifiable data
- Identifiable information
- Identified human biological materials
- Immunohistochemistry
- Impartial witness
- In-kind contribution
- Incentive
- Incidence rate
- Incidental findings
- Inclusion criteria
- Indemnification
- Independent central adjudication committee
- Independent data-monitoring committee
- Independent ethics committee
- Independent Variable
- Indication
- Indicator
- Indirect identifiers
- Indirectly identifying information
- Industry-initiated
- Industry-sponsored
- Ineligible participants
- Infectious substance
- Informed consent
- Informed consent form
- Innovation
- Inspection
- Institution
- Institutional review board
- Intellectual Property
- Intention-to-treat
- Inter-rater reliability
- Interaction
- Interactive voice response system
- Interim analysis
- Interim analysis schedule
- Interim clinical trial report
- Internal funding
- International Air Transportation Association
- International Council on Harmonization
- International Organization for Standardization
- Interpretation
- Intervention
- Interventional clinical research
- Invasive procedure
- Investigational Device Exemption
- Investigational Device Exemption Application
- Investigational New Drug
- Investigational product
- Investigational product accountability
- Investigational site
- Investigational Testing Authorization
- Investigator
- Investigator agreement
- Investigator brochure
- Investigator meeting
- Investigator-initiated clinical trial
- Investigator`s drug brochure
J
K
L
- Label
- Labeling
- Laboratory accreditation
- Laboratory certification
- Last participant complete
- Last participant in
- Last participant out
- Last patient first visit
- Last patient in
- Last patient last visit
- Last subject complete
- Last subject in
- Last subject out
- Learning Health System
- Legal authentication
- Legally acceptable representative
- Letter of Information
- Liability
- Loading dose
- Longitudinal study
- Loss to follow up
- Lot number
M
- Machine Learning
- Marketing Authorization Application
- Masked medication
- Masking
- Master protocols
- Matched-pair design
- Matching
- Material Safety Data Sheets
- Material Transfer Agreement
- Mature minor
- Maximum tolerated dose
- Mean
- Median
- Medical Device Establishment License
- Medical Device Single Audit Program
- Medical Dictionary for Regulatory Activities
- Medical history
- Medical monitor
- Medical records
- Medicines and Healthcare Products Regulatory Agency
- Memorandum of Understanding
- Meta-analysis
- Metabolism
- Metadata
- Method of research
- Micro-Randomized Trials
- Minimal risk research
- Minor
- Missing data
- Mobile Health
- Mode
- Monitor
- Monitoring
- Monitoring Plan
- Monitoring report
- Monitoring visit
- Multi-affiliation
- Multi-centre trial
- Multi-jurisdictional
- Multi-site
N
- N-of-1 study
- National Information Center on Health Services Research and Health Care Technology
- National Institute of Health
- National Library of Medicine
- National Sciences & Engineering Research Council of Canada
- Natural Health Product
- Natural language
- Negative results
- Network of Networks
- New Drug Application
- New Drug Submission
- New safety information
- No carbon required
- No Objection Letter
- Non-evaluable participant
- Non-interventional trial
- Non-invasive procedure
- Non-therapeutic trial
- Nonclinical study
- Normal distribution
- Normal ranges
- Northern Alberta Clinical Trials Research Centre
- Not approvable letter
- Not Satisfactory Notice
- Notice of authorization
- Notice of compliance
- Notice of compliance with conditions
- Notice of non-compliance
- Null hypothesis
- Numeric signature
- Nuremberg Code
O
- Objective
- Observation
- Observational clinical research
- Observer assessment
- OCAP-Access
- OCAP-Control
- OCAP-Ownership
- OCAP-Possession
- Office of the Information and Privacy Commissioner
- On follow-up
- On protocol
- Ongoing research
- Open to enrollment
- Open-label study
- Operational approval
- Operational Data Model
- Organization
- Origin
- Original data
- Orphan drug
- Outcome
- Outcomes research
- Outliers
- Over the counter
P
- P-value
- Package insert
- Packed Red Blood Cells
- Pairing
- Paraffin block
- Parallel study design
- Parallel trial
- Partial responder
- Participant
- Participant file
- Participant information
- Participant number
- Participant record
- Participant registry
- Participant screening log
- Participant status
- Participatory research
- Partnership for Research and Innovation in the Health System
- Patent
- Patient
- Patient Engagement
- Patient file
- Patient partners
- Patient specimen
- Patient-engaged research
- Patient-Oriented Research
- Patient-reported outcome
- PBS
- PCR
- Peer review
- Pending
- Per-protocol analysis set
- Performed activity
- Period effect
- Permanent data
- Permissible values
- Permission to Contact
- Personal health information
- Personal Health Number
- Personal information
- Personal Information Protection and Electronic Documents Act
- Pharmaceutical Research and Manufacturers Association
- Pharmaceutical trial
- Pharmacodynamic
- Pharmacodynamics
- Pharmacoeconomics
- Pharmacoepidemiology
- Pharmacogenetic test
- Pharmacogenetics
- Pharmacogenomic
- Pharmacogenomic test
- Pharmacogenomics
- Pharmacokinetic
- Pharmacokinetics
- Pharmacology
- Pharmacovigilance
- Phase 0
- Phase 1
- Phase 2
- Phase 2A
- Phase 3
- Phase 3B
- Phase 4
- Phase 5
- Phase of clinical research
- Phosphate buffered saline
- Pilot
- Pilot phase
- Pilot-testing
- Pivotal phase trial
- Pivotal study
- Placebo
- Placebo effect
- Placebo-controlled
- Plasma
- Platform trials (Multi-Arm, Multi-Stage (MAMS) design trials)
- Policy
- Polymerase chain reaction
- Population
- Population health data
- Post marketing surveillance
- Post study phase
- Power
- Pragmatic trial
- Pre-clinical and Clinical Evaluation Report Template
- Pre-commercial product sales
- Pre-market approval
- Pre-product testing
- Pre-screened
- Pre-screening period
- Pre-study phase
- Pre-study visit
- Precision Medicine
- Preclinical studies
- Prevention
- Primary objective
- Primary Prevention
- Primary variable
- Principal investigator
- Privacy
- Privacy Breach
- Privacy Impact Assessment
- Privacy risks
- Probability
- Procedure
- Product monograph
- Prognosis
- Program evaluation
- Proper name
- Proprietary name
- Prospective consent
- Prospective study
- Protocol
- Protocol amendment
- Protocol deviation
- Protocol number
- Protocol Safety and Efficacy Assessment Template
- Protocol violation
- Provincial Health Ethics Network
- Provincial Health Research Ethics Information System
- Proxy
- Proxy respondent
- Psychometric reliability
- Psychometric validation
- Psychometrics
- Psychotherapy trial
- Publicly available information
- Publicly declared emergency
- Purchased Services Agreement
Q
R
- Radiopharmaceuticals
- Random allocation
- Random number table
- Random sample
- Randomization
- Randomization code
- Randomized controlled trial/Randomized clinical trial
- Rapid learning health systems
- Raw data
- Real world data
- Real world evidence
- Reciprocal REB review
- Recruitment
- Recruitment log
- Recruitment period
- Recruitment target
- Reference interval
- Reference ranges
- Registry
- Registry-based trial
- Regulatory affairs
- Regulatory authorities
- Regulatory Enrolment Process
- Reimbursement
- Relative Risk Reduction
- Remote data entry
- Remote Patient Monitoring
- Repeat rule
- Replacement
- Repository
- Rescue medication
- Research
- Research agreement
- Research directive
- Research ethics
- Research ethics approval
- Research ethics board
- Research Ethics Board Attestation
- Research ethics education and training
- Research Ethics Review Committee (AIHS)
- Research involving partial disclosure of deception
- Research nurse
- Research Output
- Research participant
- Research records
- Respect for persons
- Response option
- Result synopsis
- Retrospective
- Retrospective consent
- Retrospective study
- Ribonuclease
- Risk
- Risk Reduction
- Risk-Based Monitoring
- Risk/benefit ratio
- Route of administration
- Run-in period
S
- Safety and tolerability
- Sample size
- Sample size adjustment
- Santé Canada
- Schedule of assessments
- Scientific Clinical Networks
- Scientific review
- Screen failure
- Screened
- Screening
- Screening trials
- Script
- Seamless clinical trials
- Secondary objective
- Secondary Prevention
- Secondary use
- Security
- Self-evident change
- Senior Medical Officer
- Serious adverse drug reaction
- Serious adverse event
- Serious adverse experience
- Serious unexpected adverse drug reaction
- Sex
- Shall
- Should
- Side effect
- Signature sheet
- Significance level
- Single-blind study
- Single-masked study
- Site
- Site audit
- Site closeout
- Site initiation visit
- Site investigator
- Site management organization
- Site number
- Site selection visit
- Site visit log
- Social Sciences and Humanities Research Council of Canada
- Social, cultural, environmental and population research
- Society for Clinical Data Management
- Society of Clinical Research Associates
- Soft lock
- Software as a Medical Device
- Source
- Source data
- Source data verification
- Source document verification
- Source documents
- Special populations
- Sponsor
- Sponsor-investigator
- Staging
- Standard
- Standard deviation
- Standard error of the mean
- Standard of care
- Standard operating procedure
- Standard treatment
- Statistical method
- Statistical methodology
- Statistical plan
- Statistical significance
- Stepped wedge cluster randomized trial
- Stewardship
- Stochastic
- Stopping rules
- Storage requirements
- Strategy for Patient Oriented Research
- Stratification
- Study
- Study arm
- Study coordinator
- Study database manual
- Study description
- Study design
- Study design schematic
- Study drug
- Study feasibility
- Study materials
- Study number
- Study origin
- Study population
- Study procedures manual
- Study protocol
- Study records
- Study report
- Study site
- Study start date
- Study status
- Study supplies
- Study treatment
- Sub-investigator
- Sub-site
- Subject
- Subject identification code
- Subject-reported outcome
- Substitute decision maker
- Summary of Product Characteristics
- Superiority trial
- Supportive study
- Surgical trial
- Surrogate marker
- Surrogate variable
- Survey
- Suspected unexpected serious adverse reaction
- Symptoms
- Synopsis
- System Organ Classes (from MedDra)
- Systematic Review
- Systemic and structural barriers
T
- T-test
- Target enrollment
- Target study population
- Technology assessment
- Telehealth
- Terminated
- Termination of a study
- Termination of a study participant
- Tertiary Prevention
- Therapeutic area
- Therapeutic intervention
- Therapeutic misconception
- Therapeutic ratio
- Therapeutic window
- Therapeutics Product Directorate
- Three times daily
- Tissue micro array
- Tissue processor
- Title 21 of the Code of Federal Regulations (CFR)
- Tolerability
- Tolerance
- Topic
- Toxicity
- Toxicology
- Traditional knowledge
- Transcription
- Translation
- Translational Research
- Transmit
- Treatment effect
- Treatment group
- Treatment-emergent adverse event
- Tri Council Policy Statement (2nd Edition)
- Tri-Council Policy Statement
- Trial coordinator
- Trial design model
- Trial master file
- Trial registry
- Trial statistician
- Trial subject
- Triple-blind study
- Twice a day
- Type 1 error
- Type 2 error
- Type 3
- Type of comparison
- Type of investigator/research role
U
- Umbrella trial
- Unanticipated issues
- Unblinding
- Uncontrolled clinical trial
- Undue influence
- Unexpected adverse drug reaction
- Unexpected serious risk
- Unique Lifetime Identifier
- United States of America
- University of Alberta
- University of Calgary
- University of Lethbridge
- User acceptance testing
- User site testing
V
W
- Waiver of consent
- Warning Letter
- Wash-out period
- Weighting
- Welfare
- Well-being
- WHO Drug Dictionary
- Withdrawal
- Withdrawal of a study participant
- Withdrawn
- Women and Children's Health Research Institute
- Workplace hazardous material information system
- World Health Organization
- World Health Organization Adverse Reaction Terminology
- World Health Organization Drug Dictionary
- World Medical Association
X
Y
Z